George K Babcock, MD | |
303 S Main St, Bluffton, IN 46714-2503 | |
(260) 824-3432 | |
(260) 919-3562 |
Full Name | George K Babcock |
---|---|
Gender | Male |
Speciality | Surgery |
Location | 303 S Main St, Bluffton, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073557567 | NPI | - | NPPES |
100257660 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 01024960A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
George K Babcock, MD 7916 W Jefferson Blvd, Fort Wayne, IN 46804-4140 Ph: (260) 824-3432 | George K Babcock, MD 303 S Main St, Bluffton, IN 46714-2503 Ph: (260) 824-3432 |
News Archive
ST. LOUIS - Nigerian youth are at the epicenter of an expanding HIV crisis in Sub-Saharan Africa. As a country, Nigeria ranks second in the in the world in new HIV-Infections among youth, youth living with HIV and AIDS-related death among a youth population.
Neuroscientists know that some connections in the brain are pruned through neural development. Function gives rise to structure, according to the textbooks. But scientists at the Virginia Tech Carilion Research Institute have discovered that the textbooks might be wrong.
QRxPharma announced today the successful outcome of a Phase 1 trial for MoxDuo CR, a controlled-release (CR) Dual-Opioid(TM) designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic). The purpose of the trial was to determine which of the various experimental formulations provided the optimum duration of drug levels in the blood.
Applied Spine Technologies announced today the first two Stabilimax surgeries performed outside of the United States. The surgeries were performed in Johannesburg, South Africa, by Ajay Maharaj, MD, at Sunninghill Hospital. The Stabilimax Dynamic Spine System is currently part of an IDE multi-center, randomized, controlled clinical trial in the U.S.
› Verified 8 days ago